Amgen has denied a request by the FDA to voluntarily withdraw its rare disease drug Tavneos from the market, the company said ...
A Democratic lawmaker is raising new concerns about a Food and Drug Administration program designed to drastically shorten ...
Feb 4 (Reuters) - The U.S. Food and Drug Administration on Wednesday classified Abbott's recall of certain glucose monitoring ...
Abbott has been hit with a slew of complaints from the FDA in a warning letter related to its continuous glucose monitor (CGM ...
The Food and Drug Administration recalled a honey energy supplement on Wednesday after an undeclared erectile dysfunction ...
The Consolidated Appropriations Act of 2026, signed by Trump on Feb. 3, includes a provision reinstating the Mikaela Naylon ...
The FDA has requested that Amgen voluntarily withdraw avacopan (Tavneos), a treatment for anti-neutrophil cytoplasmic ...
Rep. Jake Auchincloss of Massachusetts said the Commissioner’s National Priority Voucher program did not receive congressional backing. The FDA has also not yet made disclosures for eight senior ...
Autism researchers question motivations for latest HHS changes, including the new IACC ...
The FDA has expanded the approval of Hologic’s Aptima human papillomavirus (HPV) assay for clinician-collected primary ...
The FDA issued a recall Wednesday for a honey energy supplement after an undeclared erectile dysfunction medication was found ...
GelrinC, the only restorative product for knee cartilage repair, has CE Mark approval in Europe and is currently at the ...